Asthma trials in Belgium
17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Brussels, Edegem
- Age
- 6 years and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - No phaseTaking peopleAdvancing Diagnosis and Treatment of Pediatric Asthma
- Where
- Liège
- Age
- 5 years to 16 years
- People
- 208 worldwide
- Run by
- Luxembourg Institute of Health
See details and how to joinNCT07500246 - Phase 2Taking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Where
- Gent, Liège, Mechelen
- Age
- 18 years to 75 years
- People
- 252 worldwide
- Run by
- Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00 - Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Where
- Erpent, Mechelen
- Age
- 12 years to 80 years
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07359846 - Phase 1Taking peopleA Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
- Where
- Brussels
- Age
- 18 years to 65 years
- People
- 133 worldwide
- Run by
- Pfizer
See details and how to joinNCT07660731 · EU 2026-526260-21-00 - Phase 2Taking peopleA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Where
- Brussels, Erpent, Ghent, Liège
- Age
- 18 years to 75 years
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07323654 - Phase 2Not yet taking people in BelgiumA Long-term Study of KT-621 Administered Orally to Participants with Asthma Previously Enrolled in a KT-621 Asthma Study
- Where
- Brussels, Gent, Liège, Namur, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 77 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2026-526241-98-00 · EU 2026-526241-98-00 - Phase 2Enrolling by invitationLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Gent, Liège, Mechelen
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - Phase 2Taking peopleA Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma
- Where
- Brussels, Gent, Liège, Namur, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 121 worldwide
- Run by
- Kymera Therapeutics Inc.
See details and how to join2025-523180-38-00 · EU 2025-523180-38-00 - Phase 3Taking peopleROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
- Where
- Anderlecht, Edegem
- People
- 94 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00 - Phase 3Taking peopleA Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- Where
- Anderlecht, Edegem, Liège, Mechelen, Namur, Sint-Lambrechts-Woluwe, Thuin
- Age
- 12 years and over
- People
- 456 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07456033 · EU 2025-524463-20-00 - Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1)
- Where
- Mechelen, Namur
- People
- 80 worldwide
- Run by
- Generate Biomedicines Inc.
See details and how to join2025-524040-35-00 · EU 2025-524040-35-00 - Phase 3Taking peopleDepemokimab Asthma Imaging and Bronchoscopy Sub-Study
- Where
- Edegem, Kortrijk, Liège, Mechelen, Namur
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06979323 · EU 2024-519976-19-00 - No phaseTaking peopleSAMBA Trial: Towards a Paradigm Shift in Severe Asthma Management: Deep Analysis of the Effect of suBmaximal Aerobic Training
- Where
- Liège
- Age
- 18 years to 65 years
- People
- 100
- Run by
- University of Liege
See details and how to joinNCT04395937 - No phaseTaking peopleThe Potential Added Value of Impulse Oscillometry in Asthma Monitoring
- Where
- Brussels
- Age
- 18 years and over
- People
- 50
- Run by
- Universitair Ziekenhuis Brussel
See details and how to joinNCT06425562 - No phaseEnrolling by invitationThe Effect of Odors on Asthma Symptoms
- Where
- Leuven
- Age
- 18 years to 65 years
- People
- 48
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT02624362 - No phaseTaking peopleReal Life Study of Biologicals in Patients With Severe CRSwNP
- Where
- Ghent
- Age
- 18 years to 80 years
- People
- 180
- Run by
- University Hospital, Ghent
See details and how to joinNCT05938972